Jardiance Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Jardiance 10 mg: Round, pale yellow, biconvex, bevel-edged film-coated tablet debossed with "S10" on one side and the Boehringer Ingelheim logo on the other (tablet diameter: 9.1 mm).
Jardiance 25 mg: Oval, pale yellow, biconvex film-coated tablet debossed with "S25" on one side and the Boehringer Ingelheim logo on the other (tablet length: 11.1 mm, tablet width: 5.6 mm).
Each tablet contains 10 mg or 25 mg empagliflozin.
Excipient with known effect: Each tablet contains lactose monohydrate equivalent to 154.3 mg (10 mg Empagliflozin) or 107.4 mg (25 mg Empagliflozin) lactose anhydrous.
Excipients/Inactive Ingredients: Tablet core: Lactose monohydrate, Cellulose microcrystalline, Hydroxypropylcellulose, Croscarmellose sodium, Colloidal anhydrous silica, Magnesium stearate.
Film coating (Opadry Yellow 02B38190): Hypromellose 2910, Titanium dioxide, Talc, Macrogol 400, Iron oxide yellow.

empagliflozin

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH